Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001113423-17-000015
Filing Date
2017-05-08
Accepted
2017-05-08 16:50:49
Documents
3
Period of Report
2017-05-08

Document Format Files

Seq Description Document Type Size
1 6-K q1-2017xprx6k.htm 6-K 17034
2 EXHIBIT 99.1 q1-2017exhibit991pr.htm EX-99.1 96955
3 aeternazentarislogoa28.jpg GRAPHIC 14913
  Complete submission text file 0001113423-17-000015.txt   135837
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 17823106
SIC: 2834 Pharmaceutical Preparations